PFE logo

Pfizer Inc. (PFE) Cash From Financing

Annual CFF:

-$17.14B-$43.21B(-165.76%)
December 31, 2024

Summary

  • As of today, PFE annual cash from financing is -$17.14 billion, with the most recent change of -$43.21 billion (-165.76%) on December 31, 2024.
  • During the last 3 years, PFE annual cash from financing has fallen by -$7.32 billion (-74.61%).
  • PFE annual cash from financing is now -165.76% below its all-time high of $26.07 billion, reached on December 31, 2023.

Performance

PFE Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

Quarterly CFF:

-$3.20B+$2.03B(+38.84%)
June 29, 2025

Summary

  • As of today, PFE quarterly cash from financing is -$3.20 billion, with the most recent change of +$2.03 billion (+38.84%) on June 29, 2025.
  • Over the past year, PFE quarterly cash from financing has dropped by -$738.00 million (-30.01%).
  • PFE quarterly cash from financing is now -111.76% below its all-time high of $27.17 billion, reached on June 1, 2023.

Performance

PFE Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

TTM CFF:

-$18.17B-$738.00M(-4.23%)
June 29, 2025

Summary

  • As of today, PFE TTM cash from financing is -$18.17 billion, with the most recent change of -$738.00 million (-4.23%) on June 29, 2025.
  • Over the past year, PFE TTM cash from financing has dropped by -$12.45 billion (-217.34%).
  • PFE TTM cash from financing is now -169.72% below its all-time high of $26.07 billion, reached on December 31, 2023.

Performance

PFE TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

PFE Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-165.8%-30.0%-217.3%
3Y3 Years-74.6%-226.9%-113.6%
5Y5 Years-102.0%-134.9%-1170.3%

PFE Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-165.8%at low-111.8%+44.5%-169.7%at low
5Y5-Year-165.8%at low-111.8%+76.8%-169.7%+17.3%
All-TimeAll-Time-165.8%+25.8%-111.8%+76.8%-169.7%+21.3%

PFE Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$3.20B(+38.8%)
-$18.17B(-4.2%)
Mar 2025
-
-$5.23B(-2.2%)
-$17.44B(-1.7%)
Dec 2024
-$17.14B(-165.8%)
-$5.11B(-10.3%)
-$17.14B(-160.3%)
Sep 2024
-
-$4.64B(-88.5%)
-$6.58B(-15.0%)
Jun 2024
-
-$2.46B(+50.1%)
-$5.73B(-124.0%)
Mar 2024
-
-$4.93B(-190.6%)
$23.91B(-8.3%)
Dec 2023
$26.07B(+275.7%)
$5.44B(+244.0%)
$26.07B(+67.0%)
Sep 2023
-
-$3.78B(-113.9%)
$15.61B(+14.5%)
Jun 2023
-
$27.17B(+1080.7%)
$13.63B(+223.6%)
Mar 2023
-
-$2.77B(+44.7%)
-$11.03B(+25.7%)
Dec 2022
-$14.83B(-51.1%)
-$5.01B(+12.9%)
-$14.83B(-12.6%)
Sep 2022
-
-$5.76B(-328.6%)
-$13.17B(-54.8%)
Jun 2022
-
$2.52B(+138.3%)
-$8.51B(+37.4%)
Mar 2022
-
-$6.58B(-96.3%)
-$13.59B(-38.4%)
Dec 2021
-$9.82B(-1.7%)
-$3.35B(-204.4%)
-$9.82B(+51.5%)
Sep 2021
-
-$1.10B(+56.9%)
-$20.25B(+7.8%)
Jun 2021
-
-$2.56B(+8.9%)
-$21.97B(-114.2%)
Mar 2021
-
-$2.81B(+79.6%)
-$10.26B(-6.3%)
Dec 2020
-$9.65B(-13.7%)
-$13.79B(-388.7%)
-$9.65B(-668.3%)
Sep 2020
-
-$2.82B(-130.8%)
$1.70B(-78.2%)
Jun 2020
-
$9.16B(+516.3%)
$7.79B(+451.3%)
Mar 2020
-
-$2.20B(+9.8%)
-$2.22B(+73.9%)
Dec 2019
-$8.48B(+58.5%)
-$2.44B(-174.5%)
-$8.48B(+31.9%)
Sep 2019
-
$3.27B(+484.6%)
-$12.45B(+27.3%)
Jun 2019
-
-$851.00M(+89.9%)
-$17.13B(+5.8%)
Mar 2019
-
-$8.47B(-32.2%)
-$18.19B(+11.0%)
Dec 2018
-$20.44B(-53.1%)
-$6.41B(-355.7%)
-$20.44B(-15.3%)
Sep 2018
-
-$1.41B(+26.3%)
-$17.73B(+1.9%)
Jun 2018
-
-$1.91B(+82.2%)
-$18.08B(+5.6%)
Mar 2018
-
-$10.72B(-189.7%)
-$19.15B(-43.4%)
Dec 2017
-$13.35B(-49.6%)
-$3.70B(-110.9%)
-$13.35B(-14.5%)
Sep 2017
-
-$1.75B(+41.0%)
-$11.66B(-0.8%)
Jun 2017
-
-$2.98B(+39.5%)
-$11.56B(-73.3%)
Mar 2017
-
-$4.92B(-145.3%)
-$6.67B(+25.2%)
Dec 2016
-$8.92B(+14.3%)
-$2.01B(-20.7%)
-$8.92B(-11.2%)
Sep 2016
-
-$1.66B(-186.7%)
-$8.02B(-21.0%)
Jun 2016
-
$1.92B(+126.7%)
-$6.63B(+36.4%)
Mar 2016
-
-$7.17B(-546.6%)
-$10.42B(-1.8%)
Dec 2015
-$10.41B(-4.2%)
-$1.11B(-315.4%)
-$10.23B(+15.1%)
Sep 2015
-
-$267.00M(+85.8%)
-$12.05B(+17.9%)
Jun 2015
-
-$1.88B(+73.1%)
-$14.67B(+1.1%)
Mar 2015
-
-$6.98B(-138.6%)
-$14.84B(-48.6%)
Dec 2014
-$9.99B(+33.3%)
-$2.93B(-1.4%)
-$9.99B(+22.0%)
Sep 2014
-
-$2.89B(-41.5%)
-$12.80B(+17.6%)
Jun 2014
-
-$2.04B(+4.4%)
-$15.55B(+11.4%)
Mar 2014
-
-$2.13B(+62.9%)
-$17.54B(-17.1%)
Dec 2013
-$14.97B(+6.4%)
-$5.74B(-2.0%)
-$14.97B(+3.2%)
Sep 2013
-
-$5.63B(-39.6%)
-$15.46B(-17.8%)
Jun 2013
-
-$4.03B(-1029.5%)
-$13.12B(-8.8%)
Mar 2013
-
$434.00M(+107.0%)
-$12.06B(+24.6%)
Dec 2012
-$16.00B(+22.4%)
-$6.23B(-89.4%)
-$16.00B(+0.1%)
Sep 2012
-
-$3.29B(-10.9%)
-$16.02B(+4.4%)
Jun 2012
-
-$2.97B(+15.4%)
-$16.76B(+5.4%)
Mar 2012
-
-$3.51B(+43.9%)
-$17.71B(+14.1%)
Dec 2011
-$20.61B(-84.4%)
-$6.25B(-54.9%)
-$20.61B(-33.5%)
Sep 2011
-
-$4.04B(-3.0%)
-$15.44B(-10.9%)
Jun 2011
-
-$3.92B(+38.8%)
-$13.92B(+3.1%)
Mar 2011
-
-$6.40B(-493.5%)
-$14.37B(-28.6%)
Dec 2010
-$11.17B(-177.2%)
-$1.08B(+57.2%)
-$11.17B(+12.9%)
Sep 2010
-
-$2.52B(+42.1%)
-$12.83B(-5.7%)
Jun 2010
-
-$4.36B(-35.8%)
-$12.13B(-842.1%)
Mar 2010
-
-$3.21B(-17.4%)
$1.64B(-88.7%)
Dec 2009
$14.48B(+320.7%)
-$2.73B(-49.6%)
$14.48B(-3.2%)
Sep 2009
-
-$1.83B(-119.4%)
$14.96B(+3.8%)
Jun 2009
-
$9.41B(-2.4%)
$14.41B(+547.1%)
Mar 2009
-
$9.63B(+527.7%)
$2.23B(+133.9%)
Dec 2008
-$6.56B(+48.0%)
-$2.25B(+5.3%)
-$6.56B(-45.6%)
Sep 2008
-
-$2.38B(+14.4%)
-$4.51B(+29.4%)
Jun 2008
-
-$2.78B(-427.5%)
-$6.38B(+7.7%)
Mar 2008
-
$848.00M(+524.0%)
-$6.91B(+45.2%)
Dec 2007
-$12.61B(+45.4%)
-$200.00M(+95.3%)
-$12.61B(+24.3%)
Sep 2007
-
-$4.25B(-28.5%)
-$16.66B(+4.9%)
Jun 2007
-
-$3.31B(+31.7%)
-$17.52B(+8.7%)
Mar 2007
-
-$4.85B(-14.0%)
-$19.18B(+17.0%)
Dec 2006
-$23.10B
-$4.25B(+16.6%)
-$23.10B(-59.1%)
Sep 2006
-
-$5.10B(-2.5%)
-$14.52B(-28.7%)
DateAnnualQuarterlyTTM
Jun 2006
-
-$4.98B(+43.2%)
-$11.28B(+34.3%)
Mar 2006
-
-$8.77B(-302.6%)
-$17.17B(-86.2%)
Dec 2005
-$9.22B(-39.1%)
$4.33B(+332.3%)
-$9.22B(+45.4%)
Sep 2005
-
-$1.86B(+82.9%)
-$16.90B(+11.2%)
Jun 2005
-
-$10.87B(-1228.6%)
-$19.03B(-110.8%)
Mar 2005
-
-$818.00M(+75.6%)
-$9.03B(-36.2%)
Dec 2004
-$6.63B(+60.8%)
-$3.35B(+16.2%)
-$6.63B(+23.5%)
Sep 2004
-
-$4.00B(-360.9%)
-$8.66B(-5.3%)
Jun 2004
-
-$867.00M(-154.8%)
-$8.22B(+45.4%)
Mar 2004
-
$1.58B(+129.4%)
-$15.07B(+10.9%)
Dec 2003
-$16.91B(-238.2%)
-$5.38B(-51.4%)
-$16.91B(-16.1%)
Sep 2003
-
-$3.56B(+53.9%)
-$14.57B(-21.9%)
Jun 2003
-
-$7.72B(-2961.9%)
-$11.95B(-137.1%)
Mar 2003
-
-$252.00M(+91.7%)
-$5.04B(-0.8%)
Dec 2002
-$5.00B(-138.5%)
-$3.04B(-224.2%)
-$5.00B(-54.4%)
Sep 2002
-
-$939.00M(-16.5%)
-$3.24B(-13.7%)
Jun 2002
-
-$806.00M(-283.8%)
-$2.85B(-55.4%)
Mar 2002
-
-$210.00M(+83.6%)
-$1.83B(+12.6%)
Dec 2001
-$2.10B(+43.4%)
-$1.28B(-133.5%)
-$2.10B(+36.8%)
Sep 2001
-
-$549.00M(-362.7%)
-$3.31B(+0.9%)
Jun 2001
-
$209.00M(+144.1%)
-$3.34B(-26.7%)
Mar 2001
-
-$474.00M(+81.0%)
-$2.64B(+28.8%)
Dec 2000
-$3.71B(-223.0%)
-$2.50B(-332.7%)
-$3.71B(-44.0%)
Sep 2000
-
-$578.00M(-163.2%)
-$2.57B(-5.8%)
Jun 2000
-
$914.00M(+159.4%)
-$2.43B(+29.6%)
Mar 2000
-
-$1.54B(-12.5%)
-$3.46B(-201.5%)
Dec 1999
-$1.15B(+40.1%)
-$1.37B(-212.6%)
-$1.15B(-37.9%)
Sep 1999
-
-$438.00M(-294.6%)
-$832.00M(+19.5%)
Jun 1999
-
-$111.00M(-114.4%)
-$1.03B(+2.5%)
Mar 1999
-
$771.00M(+173.1%)
-$1.06B(+44.7%)
Dec 1998
-$1.92B(-125.9%)
-$1.05B(-64.9%)
-$1.92B(-38.3%)
Sep 1998
-
-$639.00M(-366.4%)
-$1.39B(-3.9%)
Jun 1998
-
-$137.00M(-59.3%)
-$1.33B(-24.8%)
Mar 1998
-
-$86.00M(+83.6%)
-$1.07B(-29.8%)
Dec 1997
-$848.00M(-122.0%)
-$523.00M(+10.9%)
-$823.00M(+30.0%)
Sep 1997
-
-$587.00M(-558.6%)
-$1.18B(-678.1%)
Jun 1997
-
$128.00M(-19.5%)
-$151.00M(-7.9%)
Mar 1997
-
$159.00M(+118.2%)
-$140.00M(+61.9%)
Dec 1996
-$382.00M(+26.4%)
-$875.00M(-300.2%)
-$367.00M(-192.2%)
Sep 1996
-
$437.00M(+214.4%)
-$125.60M(+84.7%)
Jun 1996
-
$139.00M(+304.4%)
-$821.40M(+32.2%)
Mar 1996
-
-$68.00M(+89.3%)
-$1.21B(-133.2%)
Dec 1995
-$519.10M(-938.6%)
-$633.60M(-144.8%)
-$519.10M(-238.4%)
Sep 1995
-
-$258.80M(-3.4%)
$375.00M(-21.9%)
Jun 1995
-
-$250.40M(-140.1%)
$480.10M(-38.0%)
Mar 1995
-
$623.70M(+139.4%)
$773.80M(+1150.1%)
Dec 1994
$61.90M(+104.0%)
$260.50M(+269.5%)
$61.90M(+104.3%)
Sep 1994
-
-$153.70M(-455.0%)
-$1.45B(+2.9%)
Jun 1994
-
$43.30M(+149.1%)
-$1.50B(+12.5%)
Mar 1994
-
-$88.20M(+93.0%)
-$1.71B(-9.2%)
Dec 1993
-$1.57B(-27.6%)
-$1.25B(-535.8%)
-$1.57B(-99.3%)
Sep 1993
-
-$197.30M(-15.2%)
-$786.20M(-42.4%)
Jun 1993
-
-$171.20M(-406.3%)
-$552.20M(+23.6%)
Mar 1993
-
$55.90M(+111.8%)
-$723.10M(+41.1%)
Dec 1992
-$1.23B(-367.6%)
-$473.60M(-1390.5%)
-$1.23B(-99.4%)
Sep 1992
-
$36.70M(+110.7%)
-$616.00M(+9.2%)
Jun 1992
-
-$342.10M(+23.8%)
-$678.40M(-145.8%)
Mar 1992
-
-$449.00M(-424.4%)
-$276.00M(-5.1%)
Dec 1991
-$262.60M(+47.5%)
$138.40M(+638.5%)
-$262.60M(+2.8%)
Sep 1991
-
-$25.70M(-142.6%)
-$270.30M(-26.7%)
Jun 1991
-
$60.30M(+113.8%)
-$213.30M(+25.4%)
Mar 1991
-
-$435.60M(-433.3%)
-$285.90M(+42.8%)
Dec 1990
-$499.90M(-624.6%)
$130.70M(+317.6%)
-$499.90M(+20.7%)
Sep 1990
-
$31.30M(+354.5%)
-$630.60M(+4.7%)
Jun 1990
-
-$12.30M(+98.1%)
-$661.90M(-1.9%)
Mar 1990
-
-$649.60M
-$649.60M
Dec 1989
$95.30M(+241.4%)
-
-
Dec 1988
-$67.40M(-3.1%)
-
-
Dec 1987
-$65.40M(+74.0%)
-
-
Dec 1986
-$252.00M(+33.6%)
-
-
Dec 1985
-$379.80M(-11.0%)
-
-
Dec 1984
-$342.20M(-40.2%)
-
-
Dec 1983
-$244.00M(+12.5%)
-
-
Dec 1982
-$278.90M(-857.9%)
-
-
Dec 1981
$36.80M(+151.1%)
-
-
Dec 1980
-$72.00M
-
-

FAQ

  • What is Pfizer Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Pfizer Inc.?
  • What is Pfizer Inc. annual cash from financing year-on-year change?
  • What is Pfizer Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Pfizer Inc.?
  • What is Pfizer Inc. quarterly cash from financing year-on-year change?
  • What is Pfizer Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Pfizer Inc.?
  • What is Pfizer Inc. TTM cash from financing year-on-year change?

What is Pfizer Inc. annual cash from financing?

The current annual cash from financing of PFE is -$17.14B

What is the all-time high annual cash from financing for Pfizer Inc.?

Pfizer Inc. all-time high annual cash from financing is $26.07B

What is Pfizer Inc. annual cash from financing year-on-year change?

Over the past year, PFE annual cash from financing has changed by -$43.21B (-165.76%)

What is Pfizer Inc. quarterly cash from financing?

The current quarterly cash from financing of PFE is -$3.20B

What is the all-time high quarterly cash from financing for Pfizer Inc.?

Pfizer Inc. all-time high quarterly cash from financing is $27.17B

What is Pfizer Inc. quarterly cash from financing year-on-year change?

Over the past year, PFE quarterly cash from financing has changed by -$738.00M (-30.01%)

What is Pfizer Inc. TTM cash from financing?

The current TTM cash from financing of PFE is -$18.17B

What is the all-time high TTM cash from financing for Pfizer Inc.?

Pfizer Inc. all-time high TTM cash from financing is $26.07B

What is Pfizer Inc. TTM cash from financing year-on-year change?

Over the past year, PFE TTM cash from financing has changed by -$12.45B (-217.34%)
On this page